Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Oxford Biomedica (OXB) Regulatory News

Date Source Headline
5th May 2023 7:00 am RNS 2023 AGM Notification
2nd May 2023 7:00 am RNS Total Voting Rights
28th Apr 2023 7:59 am RNS 2022 Annual Report and Accounts
26th Apr 2023 7:00 am RNS Board Appointment
25th Apr 2023 7:00 am RNS Preliminary results for the year ended 31 Dec 2022
19th Apr 2023 6:26 pm RNS 2022 Preliminary results revised date
3rd Apr 2023 1:19 pm RNS Total Voting Rights
30th Mar 2023 7:00 am RNS Notice of Preliminary Results
13th Mar 2023 11:33 am RNS OXB confirms no exposure to SVB receivership
1st Mar 2023 11:16 am RNS Total Voting Rights
20th Feb 2023 7:00 am RNS Dr Frank Mathias to join as new CEO on 27 March
1st Feb 2023 10:18 am RNS Total Voting Rights
27th Jan 2023 7:00 am RNS Board Change
3rd Jan 2023 5:19 pm RNS Block listing return
3rd Jan 2023 11:28 am RNS Total Voting Rights
21st Dec 2022 12:00 pm RNS Oxford Biomedica to Present at J.P Morgan
14th Dec 2022 7:00 am RNS Oxford Biomedica Solutions forms new partnerships
22nd Nov 2022 7:00 am RNS Oxford Biomedica Appoints Frank Mathias as CEO
15th Nov 2022 2:35 pm RNS Holding(s) in Company
14th Nov 2022 7:00 am RNS Sale and leaseback of Windrush Court facility
1st Nov 2022 9:14 am RNS Total Voting Rights
14th Oct 2022 2:28 pm RNS PDMR Dealings
12th Oct 2022 7:00 am RNS PDMR Dealings
12th Oct 2022 7:00 am RNS PDMR Dealings
7th Oct 2022 1:16 pm RNS PDMR Dealing Amendment
7th Oct 2022 12:28 pm RNS PDMR Dealing
7th Oct 2022 7:00 am RNS Amendment of Short-Term Loan Facility
3rd Oct 2022 9:34 am RNS Total Voting Rights
15th Sep 2022 7:00 am RNS Interim Results
14th Sep 2022 7:00 am RNS Oxford Biomedica Solutions signs new partner
7th Sep 2022 7:00 am RNS Licence & Supply Agreement with New Partner
1st Sep 2022 9:51 am RNS Total Voting Rights
25th Aug 2022 7:00 am RNS Notice of Interim Results
16th Aug 2022 7:00 am RNS Oxford Biomedica Notes Homology Q2 Report
1st Aug 2022 9:42 am RNS Total Voting Rights
27th Jul 2022 7:00 am RNS Appointment of Joint Corporate Broker
26th Jul 2022 7:00 am RNS Licence & Supply Agreement with New Partner
26th Jul 2022 7:00 am RNS New Project with Orchard Therapeutics
21st Jul 2022 7:00 am RNS Expanded Agreement with BMS’s Juno in CAR-T
15th Jul 2022 10:13 am RNS BLOCK LISTING RETURN
FTSE 100 Latest
Value8,774.65
Change-17.15